InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,346.56
(
-1.84%
)
US TECH 100
17,900.00
(
-2.65%
)
Dow Jones
39,737.26
(
-1.51%
)
Brent Oil
77.07
(
-0.37%
)
Bitcoin
58,650.37
(
-3.34%
)
Post# of 252785
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

NP1986

Send PM Follow Ignore
Followers 6
Posts 541
Boards Moderated 0
Alias Born 06/07/2011

NP1986

Re: biomaven0 post# 134284

Wednesday, 01/04/2012 12:22:36 AM

Wednesday, January 04, 2012 12:22:36 AM

Post# of 252785
My guess would be that the majority of Nexavar sales come from liver cancer. Furthermore, it is likely that much of its use in kidney cancer is in patients who are intolerant to Sutent, not as first line therapy.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up